Detalhe da pesquisa
1.
The road to tailored adjuvant chemotherapy for all four non-pancreatic periampullary cancers: An international multimethod cohort study.
Br J Cancer
; 2024 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-38806725
2.
Differences in Lymph Node Metastases Patterns Among Non-pancreatic Periampullary Cancers and Histologic Subtypes: An International Multicenter Retrospective Cohort Study and Systematic Review.
Ann Surg Oncol
; 2024 Apr 11.
Artigo
Inglês
| MEDLINE | ID: mdl-38602578
3.
Different Chemotherapy Regimens and Pathologic Complete Response in Triple-Negative Breast Cancer: An Updated Network Meta-Analysis of Phase 3 Trials.
Medicina (Kaunas)
; 60(2)2024 Feb 19.
Artigo
Inglês
| MEDLINE | ID: mdl-38399628
4.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Br J Cancer
; 128(7): 1391-1399, 2023 03.
Artigo
Inglês
| MEDLINE | ID: mdl-36759721
5.
Dignity and time perspective: A pilot explorative study in cancer patients.
Palliat Support Care
; 21(1): 43-48, 2023 02.
Artigo
Inglês
| MEDLINE | ID: mdl-35393000
6.
Early onset metastatic colorectal cancer in patients receiving panitumumab-based upfront strategy: Overall and sex-specific outcomes in the Valentino trial.
Int J Cancer
; 151(10): 1760-1769, 2022 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-35678328
7.
Cancer and Covid-19: A preliminary study on the trauma aspects of coronavirus in cancer patients.
Psychooncology
; 31(8): 1340-1346, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35394096
8.
CEA increase as a marker of disease progression after first-line induction therapy in metastatic colorectal cancer patients. A pooled analysis of TRIBE and TRIBE2 studies.
Br J Cancer
; 125(6): 839-845, 2021 09.
Artigo
Inglês
| MEDLINE | ID: mdl-34253871
9.
Treatments after progression to first-line FOLFOXIRI and bevacizumab in metastatic colorectal cancer: a pooled analysis of TRIBE and TRIBE2 studies by GONO.
Br J Cancer
; 124(1): 183-190, 2021 01.
Artigo
Inglês
| MEDLINE | ID: mdl-33024268
10.
Antibiotics and steroids, the double enemies of anticancer immunotherapy: a review of the literature.
Cancer Immunol Immunother
; 70(6): 1511-1517, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33165628
11.
Trifluridine/tipiracil in patients with metastatic gastroesophageal junction cancer: a subgroup analysis from the phase 3 TAGS study.
Gastric Cancer
; 24(4): 970-977, 2021 07.
Artigo
Inglês
| MEDLINE | ID: mdl-33713215
12.
Appropriateness of trifluridine/tipiracil in the clinical practice of third-line therapy in metastatic colorectal cancer.
Future Oncol
; 17(14): 1749-1759, 2021 May.
Artigo
Inglês
| MEDLINE | ID: mdl-33464133
13.
Italian results of the PRECONNECT study: safety and efficacy of trifluridine/tipiracil in metastatic colorectal cancer.
Future Oncol
; 17(18): 2315-2324, 2021 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-33663264
14.
Systemic doxycycline for pre-emptive treatment of anti-EGFR-related skin toxicity in patients with metastatic colorectal cancer receiving first-line panitumumab-based therapy: a post hoc analysis of the Valentino study.
Support Care Cancer
; 29(7): 3971-3980, 2021 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-33392769
15.
Red blood cell transfusions and the survival in patients with cancer undergoing curative surgery: a systematic review and meta-analysis.
Surg Today
; 51(10): 1535-1557, 2021 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-33389174
16.
Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with metastatic colorectal cancer (TRIBE2): a multicentre, open-label, phase 3, randomised, controlled trial.
Lancet Oncol
; 21(4): 497-507, 2020 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32164906
17.
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials.
Br J Cancer
; 123(3): 403-409, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32424148
18.
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).
BMC Cancer
; 20(1): 822, 2020 Aug 31.
Artigo
Inglês
| MEDLINE | ID: mdl-32867715
19.
A systematic review of salvage therapies in refractory metastatic colorectal cancer.
Int J Colorectal Dis
; 35(5): 783-794, 2020 May.
Artigo
Inglês
| MEDLINE | ID: mdl-32219509
20.
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study.
Oncologist
; 24(2): 185-192, 2019 02.
Artigo
Inglês
| MEDLINE | ID: mdl-30190299